Berberine, an alkaloid with antitumor properties, inhibits the Warburg effect in ovarian cancer cells by enhancing TET3-mediated demethylation via the TET3/miR-145/HK2 signaling pathway (88). Here, TET3 is linked to ovarian cancer.